MB

Mahesh Bhajni

Active Director Director DIN 09575267
DIN 09575267 First appointment Apr 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Mahesh Bhajni

Data last updated:

Mahesh Bhajni is a Director at Bioiv Labs Private Limited (since 2022). The company operates in Pharma. Bioiv Labs Private Limited reported revenue of ₹16.43 Cr (FY 2024).

DIN 09575267
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2022
Oldest Company Age 4 yrs
Largest company Bioiv Labs Private Limited · ₹16.43 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioiv Labs Private Limited U24290HP2022PTC009272
Director18 Apr 20222022₹16.43 Cr (FY 2024)Active

Board colleagues of Mahesh Bhajni

NameDINCompanyDesignation
Harsh Bhajni09575268Bioiv Labs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bioiv Labs Private Limited
Premium access

Shareholding and investment profile for Mahesh Bhajni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Bhajni

Mahesh Bhajni currently holds 1 directorship: Bioiv Labs Private Limited (Director, since 18 Apr 2022, revenue ₹16.43 Cr (FY 2024)).

Mahesh Bhajni was first appointed on 18 Apr 2022 as Director at Bioiv Labs Private Limited.

The current boards of Mahesh Bhajni's companies include Harsh Bhajni (Bioiv Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available